Laboratory surveillance for wild and vaccine-derived polioviruses - Worldwide, January 2007-June 2008

Morbidity and Mortality Weekly Report

Volumn 57, Issue 35, 2008, Pages 967-970

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; GENETICS; GENOTYPE; HEALTH; HUMAN; ISOLATION AND PURIFICATION; LABORATORY; MUSCLE HYPOTONIA; PARALYSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; SEROTYPING; VIROLOGY;

GENOTYPE; HUMANS; LABORATORIES; MUSCLE HYPOTONIA; PARALYSIS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; SEROTYPING; WORLD HEALTH;

EID: 51449114646     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (7)

1. CDC. Laboratory surveillance for wild and vaccine-derived polioviruses - worldwide, January 2006-June 2007. MMWR 2007;56:965-9.
2. CDC. Update on vaccine-derived polioviruses - worldwide, January 2006-August 2007. MMWR 2007;56:996-1001.
3. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 2005;59:587-635.
4. CDC. Progress toward interruption of wild poliovirus transmission - worldwide, January 2007-April 2008. MMWR 2008;57:489-94.
5. CDC. Progress toward poliomyelitis eradication - India, January 2006-September 2007. MMWR 2007;45:1187-91.
6. CDC. Progress toward poliomyelitis eradication - Pakistan and Afghanistan, 2007. MMWR 2008;57:315-9.
7. CDC. Progress toward poliomyelitis eradication - Nigeria, January 2007-August 12, 2008. MMWR 2008;57:942-6.